Definitive Contract 75A50122C00020
Award Date
3/25/22
Potential Completion Date
9/25/23
Potential Value
$740K
Awardee
Jumpcode Genomics Inc.
Ultimate Awardee
Not listed
PSC Category
AN15 - Health R&D Services; Health Care Services; Expenses For R&D Facilities And Major Equipment
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
50
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $508,865.04 firm-fixed price contract to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, California. The contract is for research and development to multiplex CRISPR-Cas13A technology for an at-home viral diagnostic, in support of the agency's efforts to enable home-based diagnostics for SARS-CoV-2 acute infection. This...
The Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Preparedness and Response (ASPR), awarded a $618,200 firm-fixed-price contract to Bugseq Bioinformatics Inc. for the development of scalable sequencing approaches to detect novel pathogens. This contract, which has a completion date of January 31, 2024, was awarded under ASPR-22-00799, a solicitation issued under the Easy Broad Agency Announcement (EZ-BAA) from the Division of Research,...
<p>The Centers for Disease Control and Prevention awarded a $3.7 million definitive cost-no-fee contract to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, to advance CRISPR-based diagnostics in response to ongoing pathogenic threats under Broad Agency Announcement topic 20.1. The place of performance will be Cambridge, Massachusetts and work is expected to be completed by January 31, 2024.</p>
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response awarded a $4,283,030.88 firm fixed price purchase order to Bioinfoexperts LLC, a woman-owned small business. The contract is for genomic sequencing of SARS-CoV-2 variants and will run for three years, with a completion date of September 26, 2026. As a small business specializing in pathogen genomics, bioinformatics, and software solutions, Bioinfoexperts will leverage its...
This is a $726,102 firm fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to The Regents of the University of California, San Francisco (UCSF) for clinical validation of a next-generation sequencing (NGS)-based diagnostic test for respiratory viral pathogens, including SARS-CoV-2. The contract is funded through ASPR's Division of Research, Innovation, and Ventures (DRIVe) and was competitively awarded without a set-aside. It includes two...
This federal contract award is for the procurement of a CRISPRMOD CRISPRA HUMAN SYNTHETIC SGRNA LIBRARY - PROTEIN KINASES - POOLS - 384 WELL, 0.1 NMOL LIBRARY by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The $16,134.60 firm fixed-price purchase order was awarded to Horizon Discovery Biosciences LIMITED, a foreign-owned, for-profit manufacturer of specialized genetic research materials, primarily...
The U.S. Department of Health and Human Services (HHS) awarded a firm fixed-price Delivery Order (DO) contract to Illumina, Inc., a manufacturer of sequencing and array-based genetic analysis solutions, to provide laboratory equipment and supplies. The $9,984 contract has an ultimate completion date of August 31, 2015 and is not designated as a set-aside. Illumina has a history of providing sequencing systems, reagents, and other products to support genomic research and diagnostics across...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,342.69 firm fixed-price purchase order was awarded to Genscript USA Inc., a biotechnology company based in New Jersey, for gene synthesis and plasmid preparation services. The contract did not have a set-aside designation. Genscript has received numerous prime and...
This federal contract award, valued at $4,263.55, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in New Jersey. The contract is for the provision of various molecular biology products and services, including gene synthesis, gene editing, custom protein and antibody production, to support biomedical research and public health initiatives. While...
This firm fixed-price contract was awarded by the National Institute of Environmental Health Sciences (NIEHS), an agency within the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $21,993.84, provides support services and deliverables such as gene synthesis, protein production, and antibody development to NIEHS. This contract is part of a larger Blanket Purchase Agreement (BPA) held by...